Order Article Reprints

Cędrowska E, Pruszyński M, Gawęda W, Żuk M, Krysiński P, Bruchertseifer F, Morgenstern A, Karageorgou M-A, Bouziotis P, Bilewicz A. Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with ²²⁵Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer. Molecules. 2020; 25(5):1025. https://doi.org/10.3390/molecules25051025

Cędrowska, Edyta, Marek Pruszyński, Weronika Gawęda, Michał Żuk, Paweł Krysiński, Frank Bruchertseifer, Alfred Morgenstern, Maria-Argyro Karageorgou, Penelope Bouziotis, and Aleksander Bilewicz. 2020. "Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with ²²⁵Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer" Molecules 25, no. 5: 1025. https://doi.org/10.3390/molecules25051025

Cędrowska, E., Pruszyński, M., Gawęda, W., Żuk, M., Krysiński, P., Bruchertseifer, F., Morgenstern, A., Karageorgou, M.-A., Bouziotis, P., & Bilewicz, A. (2020). Trastuzumab Conjugated Superparamagnetic Iron Oxide Nanoparticles Labeled with ²²⁵Ac as a Perspective Tool for Combined α-Radioimmunotherapy and Magnetic Hyperthermia of HER2-Positive Breast Cancer. Molecules, 25(5), 1025. https://doi.org/10.3390/molecules25051025